Prostaglandins and leukotrienes locally acting agents

Endocrinology: Basic and Clinical Principles: Second Edition

Volumn , Issue , 2005, Pages 93-111

  McCracken, John A ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44649093790     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59259-829-8_7     Document Type: Chapter

References (45)

1. Banu S, Arosh JA, Chapeldaine P, Fortier MA. Molecular cloning and spatio-temporal expression of the prostaglandin transporter: a basis for the action of prostaglandins in the bovine reproductive system. Proc Natl Acad Sci USA 2003;100:11, 747-11, 752.
2. Bergström S, Sjovall J. The isolation of prostaglandin. Acta Chem Scand 1957;11:1086-1087.
3. Bygdeman M, Lundstrom V. Menstruation and dysmenorrhoea. In: Curtis-Prior PB, ed. Prostaglandins: Biology and Chemistry of Prostaglandins and Related Eicosanoids. Edinburgh, UK: Churchill Livingstone 1988:490-495.
4. Capdevila JH, Falck JR. The CYP P450 arachidonic acid monoxygenases: from cell signaling to blood pressure regulation. Biochem Biophys Res Commun 2001;285:571-576.
5. Chandrasekharan NV, et al. COX-3, a cylooxygenase-1 variant inhibited by acetominophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc Natl Acad Sci USA 2002;99:13, 926-13, 931.
6. Coceani F, Bishai J, Lees J, Sirko S. Prostaglandin E2 in the pathogenesis of pyrogen fever: validation of an intermediary role. Adv Prostate Thromb Res 1989;19:394-397.
7. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology Classification of Prostanoid Receptors: properties, distribution and structure of receptors and their subtypes. Pharmacol Rev 1994;46:205-229.
8. Cundell DR, Gerard NP, Gerard C, Idanpaan-Helkklla I, Tuomanen E. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995;377:435-438.
9. Deby C. Metabolism of fatty acids, precursors of eicosanoids. In: Curtis-Prior PB, ed. Prostaglandins: Biology and Chemistry of Prostaglandins and Related Compounds. Edinburgh, UK: Churchill Livingstone 1988:11-36.
10. 2α production during luteal phase of the rhesus monkey. Biol Reprod 1993;49:809-815.
11. Engblom D, et al. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat Neurosci 2003;6:1137-1138.
12. Flower RJ. The development of COX2 inhibitors. Nat Rev Drug Discov 2003;2:179-191.
13. Fuchs AR, Helmer H, Chang SM, Fields MJ. Concentration of oxytocin receptors in the placenta and fetal membranes of cows during pregnancy and labor. J Reprod Fertil 1992;96:775-783.
14. Hayaishi O, Matsumura H, Urade Y. Prostaglandin D synthase is the key enzyme in the promotion of physiological sleep. J Lipid Mediators 1993;6:429-431.
15. Hoegy SE, Oh HR, Corcoran ML, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinase-2 (TIMP-2) supresses TKR-growth factor signaling independent of metalloproteinase inhibition. J Biol Chem 2001;276:3203-3214.
16. Klein RF, et al. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 2004;203:229-232.
17. Liotta AL, Kohn EC. The microenvironment of the tumor-host interface. Nature 2001;411:375-379.
18. Lui CH, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001;276:18, 563-18, 569.
19. McCracken JA, et al. The central oxytocin pulse generator: a pacemaker for luteolysis. Adv Exper Med Biol 1995;395:133-154.
20. McCracken JA, Custer EE, Lamsa JC. Luteolysis: a neuroendocrinemediated event. Physiol Rev 1999;79:263-323.
21. 2α identified as a luteolytic hormone in sheep. Nat New Biol 1972;238:129-134.
22. 2α: the luteolytic hormone. In: Curtis-Prior P, ed. The Eicosanoids. New York, NY: John Wiley & Sons 2004:525-545.
23. Momma K. Foetal and neonatal ductus arteriosus. In: Curtis-Prior P, ed. The Eicosanoids. New York, NY: John Wiley & Sons 2004:576-590.
24. Narumiya S, Fitzgerald GA. Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 2001;108:25-30.
25. Negeshi M, et al. Signal transduction of the isoforms of mouse prostaglandin E receptor EP3 subtype. Adv Prosta Thromb Leuk Res 1995;23:255-257.
26. O'Flaherty JT, Wykle RL. Biochemical interactions of plateletactivating factor with eicosanoids. In: Curtis-Prior P, ed. The Eicosanoids. New York, NY: John Wiley & Sons 2004:585-592.
27. Piper PF, Letts LG. Biology of leukotrienes. In: Curtis-Prior PB, ed. Prostaglandins: Biology and Chemistry of Prostaglandins and Related Eicosanoids. Edinburgh, UK: Churchill Livingstone 1988:616-624.
28. Robbiani DF, et al. The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3B, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000;103:757-786.
29. Roberts LJ II, Morrow JD. Isoprostanes: novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury. Ann NY Acad Sci 1994;744:237-242.
30. Robinson DS, Campbell D, Barnes PJ. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a doubleblind placebo-controlled trial. Lancet 2001;235:2007-2011.
31. 2α receptor in the bovine corpus luteum. DNA Seq 2002;13:307-311.
32. Samuelsson B, et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987;2:1171-1176.
33. Shemesh M, et al. Expression of functional LH receptor and its messenger ribonucleic acid in bovine uterine veins: LH induction of cyclooxygenase and augmentation of prostaglandin production in bovine uterine veins. Endocrinology 1997;138:4844-4851.
34. Skarnes RC, Brown SK, Hull SS, McCracken JA. Role of prostaglandin E in the biphasic fever response to endotoxin. J Exp Med 1981;154:1212-1224.
35. Sorensen PW, Goetz FW. Pheromonal and reproductive function of F prostaglandins and their metabolites in teleost fish. J Lipid Mediators 1993;6:385-393.
36. Stjernschantz J, et al. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment. Prog Retin Eye Res 2000;19:459-596.
37. Sugimoto Y, Narumiya S, Ichikawa. Distribution and function of prostanoid receptors: studies from knockout mice. Prog Lipid Res 2000;39:289-314.
38. 2αinduced luteolysis in sheep. Biol Reprod 2002;66:1515-1521.
39. Vanderhoek JY. Regulation of lipoxygenase enzymes in leukocytes. Immunol Ser 1992;57:77-86.
40. von Euler US. Biology of prostanoids. In: Curtis-Prior PB, ed. Prostaglandins: Biology and Chemistry of Prostaglandins and Related Eicosanoids. Edinburgh, UK: Churchill Livingstone 1988:1-7.
41. Watanabe K, et al. Role of prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res 1999;59:5093-5096.
42. Weggen S, et al. A subset of NSAIDs lower amyloidogenic Aß42 independently of cyclooxygenase activity. Nature 2001;414:212-216.
43. Weissmann G. Prostaglandins as modulators rather then mediators of inflammation. J Lipid Mediators 1993;6:275-286.
44. Yokomizo T, et al. A second leukotriene B4 receptor, BLT2: a new therapeutic target in inflammation and immunological disorders. J Exp Med 2000;192:421-431.
45. Zurier RB. Prostaglandins: then and now and next. Semin Arthritis Rheum 2003;33:137-139.